header.html

An official website of the European Union How do you know?      
European Commission logo

handle.jsp

cover
The approval of safe and effective LNP-mRNA vaccines during the SARS-CoV2 pandemic is catalysing the development of the next generation of mRNA therapeutics. Proper characterisation methods are crucial for assessing the quality and efficacy of these complex formulations. Here we show that analytical ultracentrifugation (AUC) can measure, simultaneously and without any sample preparation step, the sedimentation coefficients of both the LNP-mRNA formulation and of the mRNA molecules. This allows measuring several quality attributes, such as particle size distribution, encapsulation efficiency and density of the formulation. The technique can also be applied to study the stability of the formulation under stress conditions and different buffers.
2024-06-21
MDPI
JRC137564
1422-0067 (online),   
https://www.mdpi.com/1422-0067/25/11/5718,    https://publications.jrc.ec.europa.eu/repository/handle/JRC137564,   
10.3390/ijms25115718 (online),   
NameCountryCityType
Datasets
IDTitlePublic URL
Dataset collections
IDAcronymTitlePublic URL
Scripts / source codes
DescriptionPublic URL
Additional supporting files
File nameDescriptionFile type 

footer.html